TOKYO -- Fujifilm Holdings will spend 90 billion yen ($813 million) on biologics manufacturing unit Fujifilm Diosynth Biotechnologies, the company announced Tuesday, accelerating its push into a field that is experiencing surging demand amid the coronavirus pandemic.
Pharmaceuticals
Fujifilm injects $800m into biologics production unit
Investment to double vaccine component output in US and expand UK facility
Fujifilm sees contract development and manufacturing of biologics as a key driver for growth. © Reuters
Read Next
Latest on Pharmaceuticals
